J A Katzmann

Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma

Jeremy T. Larsen, Shaji Kumar, Angela Dispenzieri et al. · Leukemia · 2012 · 231 citations · Full text

Hematological Malignancy, Biomarker (Medicine), Oncology +9

Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12 482 persons from the National Health and Nutritional Examination Survey

Ola Landgren, Barry I. Graubard, J A Katzmann et al. · Leukemia · 2014 · 195 citations · Full text

Medicine, Health Disparities, National Health +7

Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging system

Christine L.H. Snozek, J A Katzmann, Robert A. Kyle et al. · Leukemia · 2008 · 167 citations · Full text

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +10

Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10–49 years old: a population-based study from the National Health and Nutrition Examination Survey

Ola Landgren, Barry I. Graubard, Shaji Kumar et al. · Blood Cancer Journal · 2017 · 110 citations · Full text

Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUS

J A Katzmann, Raynell Clark, Robert A. Kyle et al. · Leukemia · 2012 · 109 citations · Full text

Immunogenetics, Allergy, Autoimmune Disease +11